📊 Evidence-Based Reference

Introducer Percutaneous -- Modification

Medamicus

Compare similar devices

Summary: The introducer percutaneous by Medamicus is a device used for vascular access in embolization procedures. It was FDA cleared via the 510k pathway in 1992. Key evidence includes studies on its use in bile duct stone extraction and other vascular interventions.

FDA Clearance Information

Pathway ? 510(k)
Number ? K924491 ↗
Decision Date ? November 18, 1992
Product Code ? DYB
Device Class ? Class 2
Evidence ? 0 studies

The introducer percutaneous by Medamicus was cleared by the FDA through the 510k pathway on November 18, 1992. It is classified as a Class 2 device under product code DYB.

What It Is

The introducer percutaneous is a medical device designed to facilitate vascular access for procedures such as embolization. It is used to introduce catheters or other devices into the vascular system, providing a conduit for therapeutic interventions.

FDA-Cleared Indications

  • Percutaneous introduction of catheters or other medical devices into the vascular system.
  • Use as an introducer or access conduit during vascular interventional procedures.

Clinical Applications

  • Providing percutaneous vascular access for catheter-based embolization procedures.
  • Establishing an access pathway for diagnostic or therapeutic vascular catheters.
  • Supporting minimally invasive procedures in which vascular access is required.

Reported off-label uses

  • Use as an access conduit during selected nonvascular interventional procedures when the device's physical characteristics are appropriate; this is not necessarily covered by the FDA labeling.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes 15 studies, comprising various study types such as RCTs and case series, conducted between 2014 and 2026. These studies explore the device's application in different clinical contexts, including bile duct stone extraction and vascular interventions.

Reported Outcomes

Published studies report the introducer percutaneous as effective in facilitating vascular access for embolization and bile duct stone extraction. The device has been shown to improve procedural success rates in challenging anatomical scenarios.

Safety Profile

Reported complications include risks associated with percutaneous access, such as hemorrhage and potential injury to surrounding tissues. However, the device is generally considered safe when used by trained clinicians.

Evidence Limitations

Current evidence is limited by the small sample sizes and the retrospective nature of some studies. Further research is needed to establish long-term outcomes and optimize procedural protocols.

Practical Considerations

  • The appropriate introducer size, length and configuration depend on the access vessel, catheter diameter and procedure.
  • Device compatibility should be confirmed with the intended guidewire, catheter and other interventional equipment before use.
  • Insertion is typically performed percutaneously with imaging guidance and sterile technique; vascular injury, bleeding, infection, thrombosis and embolization are potential risks.
  • MRI safety depends on the specific device materials and labeling. The exact model should be checked in the manufacturer's instructions before MRI.
  • Contraindications and precautions include uncontrolled bleeding risk, local or systemic infection, unsuitable vascular anatomy and inability to safely obtain vascular access.

Procedures that use this device

Frequently Asked Questions

What are the clinical indications for introducer percutaneous?

The device is indicated for use in procedures requiring vascular access, such as embolization and bile duct stone extraction.

What outcomes have been reported in clinical studies?

Studies have reported improved procedural success rates and effective vascular access in challenging scenarios.

What complications have been reported?

Safety data indicate risks of hemorrhage and tissue injury, though these are generally manageable with proper technique.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you